• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

ViiV Healthcare

Blue race track
Marketing

ViiV tops US patient groups' pharma reputation ranking

After placing first in a survey of how global patient groups view pharmas, ViiV Healthcare took the top spot in a U.S. version of the survey, too.
Andrea Park May 19, 2025 2:58pm
reputation rating ranking

Pharma industry reputation slips again in patient group survey

Apr 29, 2025 2:00am
ViiV HQ

GSK’s ViiV plots next steps to fight HIV in Black communities

Feb 7, 2025 1:58pm
ViiV Healthcare Navigating HIV campaign

ViiV video series encourages deeper talks about life with HIV

Dec 6, 2024 4:10pm
Apretude US vial

GSK to triple long-acting Apretude supply to boost global access

Oct 7, 2024 10:56am
Blue Cross Blue Shield of NC removes HIV drugs from costly price tiers

WHO flags increasing resistance to GSK's Tivicay in 4 countries

Mar 6, 2024 2:02pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings